X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CLINICAL AND EXPERIMENTAL MEDICINE

期刊標題檢索 CLIN EXP MED 最新評論: Review speed: 1.0 | Submission hit rate: 75.0 Emphasized research di... (2024-08-25)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CLINICAL AND EXPERIMENTAL MEDICINE]您好,您是該頁面的第 57120 位訪客。

期刊簡介
期刊名稱CLINICAL AND EXPERIMENTAL MEDICINE CLINICAL AND EXPERIMENTAL MEDICINE
LetPub Score
6.2
50 ratings
Rate

Reputation
7.5

Influence
4.9

Speed
6.9

期刊簡稱CLIN EXP MED
ISSN1591-8890
E-ISSN1591-9528
h-index39
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.801.0381.145
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: General Biochemistry, Genetics and Molecular Biology
Q281 / 221

自引率 (2023-2024)3.10%自引率趨勢
掲載範囲
Clinical and Experimental Medicine (CEM) is a multidisciplinary journal that aims to be a forum of scientific excellence and information exchange in relation to the basic and clinical features of the following fields: hematology, onco-hematology, oncology, virology, immunology, and rheumatology. The journal publishes reviews and editorials, experimental and preclinical studies, translational research, prospectively designed clinical trials, and epidemiological studies. Papers containing new clinical or experimental data that are likely to contribute to changes in clinical practice or the way in which a disease is thought about will be given priority due to their immediate importance. Case reports will be accepted on an exceptional basis only, and their submission is discouraged. The major criteria for publication are clarity, scientific soundness, and advances in knowledge. In compliance with the overwhelmingly prevailing request by the international scientific community, and with respect for eco-compatibility issues, CEM is now published exclusively online.
官方網站https://www.springer.com/10238
在線稿件提交https://submission.nature.com/new-submission/10238/3
開放訪問No
出版商Springer International Publishing
主題領域医学
出版國/地區ITALY
發行頻率四半期刊行
創刊年2001
每年文章數246每年文章數趨勢
黃金OA百分比27.58%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ281/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1591-8890%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2.5 Month(s)
競爭力 *來自作者的數據: About 77.5%
參考鏈接
相關期刊 【CLINICAL AND EXPERIMENTAL MEDICINE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    JOURNAL OF CLINICAL INVESTIGATIONH-index: 447

    CiteScore: 24.50
    EMBO Molecular MedicineH-index: 90

    CiteScore: 17.70
    JOURNAL OF BIOMEDICAL SCIENCEH-index: 71

    CiteScore: 18.50
    CLINICAL SCIENCEH-index: 126

    CiteScore: 11.40
    Journal of Translational MedicineH-index: 87

    CiteScore: 10.00
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINEH-index: 80

    CiteScore: 12.30
    JOURNAL OF MOLECULAR MEDICINE-JMMH-index: 127

    CiteScore: 9.30
    ARCHIVES OF MEDICAL RESEARCHH-index: 72

    CiteScore: 12.50
    Orphanet Journal of Rare DiseasesH-index: 87

    CiteScore: 6.30
    XENOTRANSPLANTATIONH-index: 56

    CiteScore: 6.80
    學科內最受檢索的期刊 頁面查看次數
    Journal of Translational Medicine258095
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE175289
    JOURNAL OF CLINICAL INVESTIGATION168435
    JOURNAL OF BIOMEDICAL SCIENCE131684
    MEDICAL HYPOTHESES103204
    CLINICAL SCIENCE88291
    MEDICAL SCIENCE MONITOR84781
    Advances in Experimental Medicine and Biology81196
    EMBO Molecular Medicine79561
    EXPERIMENTAL BIOLOGY AND MEDICINE76113
  •  

    CLINICAL AND EXPERIMENTAL MEDICINE CLINICAL AND EXPERIMENTAL MEDICINE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/8)
  [CLINICAL AND EXPERIMENTAL MEDICINE] 的評論撰寫評論
作者: 东海博学


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-25 15:39:46 評論於
Review speed: 1.0 | Submission hit rate: 75.0 Emphasized research direction: cell therapy; tumor immunity Experience sharing: Resubmitted on July 15, 2024, received review comments on July 30, 2024, minor revisions, 3 questions. Revised on August 8. Accepted on August 18. Proof on August 22.
(0) 讚! | 东海博学

作者: 407928215


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-01 11:31:46 評論於
How much does it cost?
(0) 讚! | 407928215

作者: 月河莉霞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-10 17:05:24 評論於
Research focus: Oncology experience sharing: It doesn't feel as fast as I imagined. I have seen articles being accepted in just one month recently. It has been almost a month since I submitted, and it still says "Your submission has passed technical checks." The publication fee is quite expensive.
(0) 讚! | 月河莉霞

作者: 北风窅恒


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-09 14:01:37 評論於
All OA has been started, but the layout fee is still very expensive.
(0) 讚! | 北风窅恒

作者: 文章666


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-13 16:04:34 評論於
Is it currently only available to choose open, for a fee?
(0) 讚! | 文章666

作者: Ron Truman


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-25 13:36:42 評論於
How are you doing now?
(0) 讚! | Ron Truman

作者: 罗朝天


領域: 医学
審稿時間: 12.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-24 16:15:28 評論於
Slow, very slow
(0) 讚! | 罗朝天

作者: hepa


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-04-16 08:02:18 評論於
I wrote a review of lncrna, submitted it for revisions ten days ago, received the revisions in three days. Is there anyone faster than me?
(0) 讚! | hepa

作者: 苍风诗云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-15 08:53:58 評論於
Just got accepted today, so fast
(0) 讚! | 苍风诗云

作者: 灵犀雪梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-12 16:34:15 評論於
The paper submitted last June was still non-OA, with no article processing charges. But the one submitted yesterday has somehow become OA
(0) 讚! | 灵犀雪梦

作者: 灵犀雪梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-12 11:42:39 評論於
Bro, everything going well?
(0) 讚! | 灵犀雪梦

作者: 苍风诗云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-02 13:14:45 評論於
Review Speed: 1.0 Experience Sharing: I submitted a review article on microRNA related to tumor ten days ago and it was returned for revisions. I hope it will be accepted smoothly
(0) 讚! | 苍风诗云

作者: 无冬叶吉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-12 09:16:40 評論於
I hope there are no unexpected problems, the publication is pretty good
(0) 讚! | 无冬叶吉

作者: 玉景开济


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-06 12:39:51 評論於
I asked and they said that proof will start next week, but I'm not sure if it's true. The official website should also be updated by January
(0) 讚! | 玉景开济

作者: 碧桃瑞红


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-27 21:36:53 評論於
I am too
(0) 讚! | 碧桃瑞红

作者: 无冬叶吉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-26 10:23:16 評論於
I stopped recently and I don't know why
(0) 讚! | 无冬叶吉

作者: 碧桃瑞红


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-22 23:51:29 評論於
It's been a month, still inviting reviewers. If we still can't find any, I'll start to panic
(0) 讚! | 碧桃瑞红

作者: 玉景开济


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-18 11:46:44 評論於
Has this magazine stopped proofreading now? Because they're going fully open access? Or was it always this slow?
(0) 讚! | 玉景开济

作者: Kim Micah


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-07 12:49:26 評論於
Review speed: 6.0 | Submission acceptance rate: 75.0
Research focus: Tumors; Sharing experience in Meta-analysis: Submitted a Meta-analysis on June 1st, reviewed on June 3rd, revised on October 30th, resubmitted on November 1st, accepted on November 7th. During the external review process, contacted the editor multiple times and received patient replies, overall it was acceptable
(0) 讚! | Kim Micah

作者: 金顶平婉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-16 19:34:58 評論於
Submitted 2 papers, both rejected after over 3 months of submission due to no review comments. Time wasted! Exercise caution when submitting.

——————No.1——————
2022.9.30 submission received
2022.9.30 reviewers invited (21)
2022.12.28 reviewers invited (22)
2023.1.10 no reviewer accepted review invitation → rejected

——————No.2——————
2023.5.17 submission received
2023.5.18 reviewers invited (27)
2023.5.25 one reviewer accepted to review
2023.8.27 only one reviewer found and no review comments returned → rejected
(0) 讚! | 金顶平婉

作者: 灵犀雪梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-28 12:30:06 評論於
It doesn't matter, when submitting your article, we just mention that there are a few ways to pay for the submission fee, but we don't let you choose
(0) 讚! | 灵犀雪梦

作者: 千斤凯唱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-28 08:58:15 評論於
I think the editor is quite irresponsible overall, so be careful when submitting! I've wasted seven months on this, and I didn't even receive any editing feedback!
(0) 讚! | 千斤凯唱

作者: Bert Richards


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-27 18:00:46 評論於
Hello, I would like to ask again. When I submitted the manuscript, I forgot whether I chose OA or non-OA publication. Will it have any impact if I choose non-OA when signing the agreement?
(0) 讚! | Bert Richards

作者: 千斤凯唱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-26 23:20:55 評論於
Well, it's been 7 months and the two reviewers we finally found didn't provide any feedback, so our paper got rejected in the end!
(0) 讚! | 千斤凯唱

作者: 灵犀雪梦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-25 10:19:44 評論於
Within a week
(0) 讚! | 灵犀雪梦

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/8)

開始撰寫 [CLINICAL AND EXPERIMENTAL MEDICINE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*